Home/Filings/4/0000930413-11-005490
4//SEC Filing

Buchbinder Aby 4

Accession 0000930413-11-005490

CIK 0000727510other

Filed

Aug 15, 8:00 PM ET

Accepted

Aug 16, 12:26 PM ET

Size

5.6 KB

Accession

0000930413-11-005490

Insider Transaction Report

Form 4
Period: 2011-08-12
Buchbinder Aby
VP, Clinical Development
Transactions
  • Award

    Common Stock

    2011-08-12+8,00059,667 total
Footnotes (2)
  • [F1]Restricted Stock Units granted by the Issuer pursuant to its 2011 Stock Option and Incentive Plan and qualified under Rule 16b-3(d). Each unit represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F2]The Restricted Stock Units shall vest in full on August 12, 2014, if the Reporting Person remains employed by the Issuer on such date, and do not have an expiration date; provided, however, that the vesting of 50% of the Restricted Stock Units shall be accelerated upon the Reporting Person's achievement of certain performance milestones determined by the Board of Directors of the Issuer.

Issuer

ENZON PHARMACEUTICALS INC

CIK 0000727510

Entity typeother

Related Parties

1
  • filerCIK 0001526633

Filing Metadata

Form type
4
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 12:26 PM ET
Size
5.6 KB